{
  "trial_id": "NCT00909480",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of diabetes, baseline HbA1c, body mass index (BMI), baseline fasting plasma glucose, concomitant medications, ethnicity, baseline metformin dose, presence of additional oral anti-diabetic drugs (OADs).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "HbA1c (Glycosylated haemoglobin A1c)",
          "baseline HbA1c"
        ],
        [
          "Fasting Plasma Glucose (FPG)",
          "baseline fasting plasma glucose"
        ],
        [
          "Race/Ethnicity",
          "ethnicity"
        ],
        [
          "Diabetes History",
          "duration of diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Weight",
        "Region of Enrolment",
        "Height",
        "Stratification"
      ],
      "remaining_candidate_features": [
        "concomitant medications",
        "baseline metformin dose",
        "presence of additional oral anti-diabetic drugs (OADs)"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Body Mass Index, Concomitant Anti-diabetic Medications, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ],
        [
          "HbA1c (Glycosylated haemoglobin A1c)",
          "Baseline HbA1c"
        ],
        [
          "Fasting Plasma Glucose (FPG)",
          "Fasting Plasma Glucose"
        ],
        [
          "Region of Enrolment",
          "Region of Enrollment"
        ],
        [
          "Diabetes History",
          "Duration of Diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Weight",
        "Height",
        "Stratification"
      ],
      "remaining_candidate_features": [
        "Concomitant Anti-diabetic Medications",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "##Answer:\nAge, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Region of Enrollment, Diabetes duration, Body Mass Index, HbA1c, Metformin dose, Anti-diabetic drug use,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Ethnicity (NIH/OMB)"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ],
        [
          "HbA1c (Glycosylated haemoglobin A1c)",
          "HbA1c"
        ],
        [
          "Region of Enrolment",
          "Region of Enrollment"
        ],
        [
          "Diabetes History",
          "Diabetes duration"
        ]
      ],
      "remaining_reference_features": [
        "Weight",
        "Fasting Plasma Glucose (FPG)",
        "Height",
        "Stratification"
      ],
      "remaining_candidate_features": [
        "Metformin dose",
        "Anti-diabetic drug use"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c at baseline, fasting plasma glucose at baseline, metformin dose, use of other oral anti-diabetic drugs (OADs), systolic and diastolic blood pressure, history of cardiovascular disease, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "HbA1c (Glycosylated haemoglobin A1c)",
          "HbA1c at baseline"
        ],
        [
          "Fasting Plasma Glucose (FPG)",
          "fasting plasma glucose at baseline"
        ],
        [
          "Diabetes History",
          "duration of type 2 diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Weight",
        "Region of Enrolment",
        "Height",
        "Stratification"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "metformin dose",
        "use of other oral anti-diabetic drugs (OADs)",
        "systolic and diastolic blood pressure",
        "history of cardiovascular disease",
        "smoking status."
      ]
    }
  }
}